Poređenje i vrednovanje simptoma nakon nekomplikovane ureteroskopske litotripsije kod bolesnika sa i bez ugrađenog stenta

  • Slaviša Č Savić KBC Dr Dragiša Mišović, Beograd
  • Vinka Vukotić Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia
  • Miodrag Lazić Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia
  • Nataša Savić Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia
Ključne reči: ureteroscopy||, ||ureteroskopija, lithotripsy||, ||litotripsija, stents||, ||stentovi, lower urinary tract symptoms||, ||urinarni trakt, donji, simptomi, comparative study||, ||komparativna studija.,

Sažetak


Uvod/Cilj. Ureterorenoskopsko sitnjenje i uklanjanje kamena predstavlja lečenje izbora prilikom zbrinjavanja ureteralnog kamena naročito srednjeg i donjeg uretera, i smatra se osnovnim zbrinjavanjem. Cilj rada bio je da se ocene simptomi, neophodnost potencijalne koristi i neželjeni efekti plasiranja ureteralnog stenta nakon nekomplikovane ureteroskopske litotripsije (URSL). Metode. U ovoj retrospektivno-prospektivnoj studiji, ispitano je 125 bolesnika koji su bili podvrgnuti URSL. Bolesnici su podeljeni u dve grupe: sa ugrađenim stentom (ispitivani bolesnici, 59) i bez stenta (kontrole, 66 bolesnika). Ishodi koji su mereni i poređeni između dve grupe obuhvatali su: stopu odsustva kalkulusa, postoperativni bol kod bolesnika ocenjen pomoću skale, simptome donjeg urinarnog trakta (SDUT), potrebu za neplaniranim bolničkim lečenjem, komplikacije povezane sa stentom i funkcionalni oporavak u formi povratka na uobičajene fizičke aktivnosti. Rezultati. Povoljan ishod, definisan kao odsustvo kalkulusa nakon 12 nedelja, postignut je kod svih 125 (100%) bolesnika. Nije bilo statistički značajne razlike između dve grupe u stopi odsustva kalkulusa. SDUT su bili češći u grupi sa plasiranim stentom, sa statistički značajnom razlikom u domenu učestalosti mokrenja, odnosno urgencije (p = 0,0314). Postojala je statistički značajna razlika između grupa u prosečnom trajanju operacije i prosečnoj hospitalizaciji, srednjoj vrednosti ocene bola na vizualnoj analognoj skali (VAS) i u upotrebi neopijatnih analgetika. Na dan operacije i sve do trećeg postoperativnog dana (POD 3), odnosno petog postoperativnog dana (POD 5), ocena bola (p = 0,0001), kao i potreba za neopijatnim analgeticima (p = 0.001) bila je viša među bolesnicima sa stentom u poređenju sa kontrolama. Zaključak. Rutinsko ugrađivanje ureteralnog stenta nakon nekomplikovane URSL nije obavezno i može biti povezano sa neželjenim efektima stenta. URSL je bezbedna procedura i bez ugrađivanja stenta na kraju intervencije.

Biografije autora

Slaviša Č Savić, KBC Dr Dragiša Mišović, Beograd
Uroligija
Vinka Vukotić, Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia
Urology
Miodrag Lazić, Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia
Urology
Nataša Savić, Department of Urology, University Hospital “Dr. D. Mišović” Clinical Center, Belgrade, Serbia
Urology

Reference

Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol 1997; 158(5): 1915−21.

Saltzman B. Ureteral stents. Indications, variations and compli-cations. Urol Clin North Am 1988; 15(3): 481−91.

Aoyagi T, Hatano T, Tachibana M, Hata M. Short-term ureteral catheter stenting after uncomplicated transurethral uretero-lithotomy. World J Urol 2004; 22(6): 449−51.

Faqih SR, Shamsuddin AB, Chakrabarti A, Atassi R, Kardar AH, Osman MK, et al. Polyurethane internal ureteral stents in treat-ment of stone patients: morbidity related to indwelling times. J Urol 1991; 146(6): 1487−91.

Richter S, Ringel A, Shalev M, Nissenkorn I. The indwelling ureteric stent: a ‘friendly’ procedure with unfriendly high morbidity. Br J Urol 2000; 85(4): 408−11.

Denstedt JD, Wollin TA, Sofer M, Nott L, Weir M, D'A Honey RJ. A prospective randomized controlled trial comparing non-stented versus stented ureteroscopic lithotripsy. J Urol 2001; 165(5): 1419−22.

Wu C, Shee J, Lin W, Lin C, Chen C. Comparison between extracorporeal shock wave lithotripsy and semirigid ureterore-noscope with holmium:YAG laser lithotripsy for treating large proximal ureteral stones. J Urol 2004; 172(5 Pt 1): 1899−902.

Byrne RR, Auge BK, Kourambas J, Munver R, Delvecchio F, Preminger GM. Routine ureteral stenting is not necessary after ureteros-copy and ureteropyeloscopy: a randomized trial. J Endourol 2002; 16(1): 9−13.

Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX, Timoney AG, Barry MJ. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 2003; 169(3): 1065−9.

Duvdevani M, Chew BH, Denstedt JD. Minimizing symptoms in patients with ureteric stents. Curr Opin Urol 2006; 16(2): 77−82.

Ibrahim HM, Al-Kandari AM, Shaaban HS, Elshebini YH, Shokeir AA. Role of Ureteral Stenting After Uncomplicated Ureteros-copy for Distal Ureteral Stones: A Randomized, Controlled Trial. J Urol 2008; 180(3): 961−5.

Pollard SG, Macfarlane R. Symptoms arising from Double-J ure-teral stents. J Urol 1988; 139(1): 37−8.

Bregg K, Riehle RA. Morbidity associated with indwelling inter-nal ureteral stents after shock wave lithotripsy. J Urol 1989; 141(3): 510−2.

Kuyumcuoglu U, Eryildirim B, Tuncer M, Faydaci G, Tarhan F, Ozgül A. Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Can Urol Assoc J 2012; 6(6): E234−7.

Borboroglu PG, Amling CL, Schenkman NS, Monga M, Ward JF, Piper NY, et al. Ureteral stenting after ureteroscopy for distal ureteral calculi: a multi-institutional prospective randomized controlled study assessing pain, outcomes and complications. J Urol 2001; 166(5): 1651−7.

Leibovici D, Cooper A, Lindner A, Ostrowsky R, Kleinmann J, Veli-kanov S, et al. Ureteral stents: morbidity and impact on quality of life. Isr Med Assoc J 2005; 7(8): 491−4.

Joshi HB, Newns N, Stainthorpe A, Macdonagh RP, Keeley FX, Ti-money AG. Ureteral Stent Symptom Questionnaire: Develop-ment and Validation of a Multidimensional Quality of Life Measure. J Urol 2003; 169(3): 1060−4.

Damiano R, Autorino R, Esposito C, Cantiello F, Sacco R, de Sio M, et al. Stent Positioning after Ureteroscopy for Urinary Calculi: The Question Is Still Open. Eur Urol 2004; 46(3): 381−8.

Keeley FX, Timoney AG. Routine stenting after ureteroscopy: think again. Eur Urol 2007; 52(3): 642−4.

Falahatkar S, Salehi M, Asgari SA, Sharifi SH, Akbarpour M, Khaledi F, et al. Is Ureteral Stenting Necessary After Uncom-plicated Ureteroscopy Lithotripsy for Small Middle and Distal Ureteral Stones. Urotoday Int J 2009; 2(5): doi:10.3834/uij.1944-5784.2009.10.12

Jeong H, Kwak C, Lee SE. Ureteric stenting after ureteroscopy for ureteric stones: a prospective randomized study assessing symptoms and complications. BJU Int 2004; 93(7): 1032−4.

Srivastava A, Gupta R, Kumar A, Kapoor R, Mandhani A. Routine stenting after ureteroscopy for distal ureteral calculi is unne-cessary: results of a randomized controlled trial. J Endourol 2003; 17(10): 871−4.

Objavljeno
2017/03/10
Broj časopisa
Rubrika
Originalni članak